Skip to content
Recall Observatory FDA recall evidence

Drug product

Paliperidone Extended Release Tablets 9 mg, packaged in a) 30-count bottle(NDC 0591-3695-30) , b) 90-count bottle (NDC 0591-3695-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054

D-0097-2019

August 06, 2018

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 80790
Status
Terminated
Classification
Class II
Quantity
3,785 bottles
Official record key
drug-enforcement:D-0097-2019

Official wording

Reason: Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Code information: Lot #: a) 1291192A, Exp 01/2020; b) 1291193A, Exp 01/2020

Distribution pattern: Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.